Cross-Border Transactions INTERNATIONAL PRACTICES

WilmerHale's corporate lawyers have a long history of experience with cross-border deals involving mergers and acquisitions, public offerings and capital markets, venture capital, joint ventures and other transactions.


Our team counsels companies across industries, drawing on the firm's internationally recognized life sciences, technology and financial services capabilities, to counsel pharmaceutical companies, medical device developers, software and Internet companies, semiconductor manufacturers, fin tech providers and a wide range of other clients. Our transactional lawyers are backed by regulatory lawyers with deep experience in Committee on Foreign Investment in the United States (CFIUS) and Foreign Corrupt Practices Act (FCPA) requirements, as well as by securities, tax, real estate, antitrust and intellectual property practitioners who are ready to meet the diverse needs of all clients.

Bain, Mick

Mick Bain

Partner

+1 617 526 6158 (t)

michael.bain@wilmerhale.com

Bonnes, Andrew

Andrew Bonnes

Partner

+1 617 526 6136 (t)

andrew.bonnes@wilmerhale.com

Boot, Jeannette K.

Jeannette K. Boot

Partner

+1 212 295 6507 (t)

jeannette.boot@wilmerhale.com

Borden, Mark G.

Mark G. Borden

Partner

+1 617 526 6675 (t)

mark.borden@wilmerhale.com

Bothwick, Jay E.

Jay E. Bothwick

Partner

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Braun, Martin

Dr. Martin Braun

Partner

+49 69 27 10 78 207 (t)

martin.braun@wilmerhale.com

Buckland, Peter

Peter Buckland

Partner

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Conahan, Joseph B.

Joseph B. Conahan

Partner

+1 617 526 6317 (t)

joseph.conahan@wilmerhale.com

Publications & News

View

December 6, 2017

WilmerHale Represents Regal Entertainment Group in Signing of Definitive Agreement to Be Acquired by Cineworld Group PLC

Regal Entertainment Group announced that it has entered into a definitive merger agreement with Cineworld Group PLC for Cineworld, the UK's largest cinema operator.

June 7, 2017

Selected 2017 Life Sciences Transactions

Recognized both globally and nationally for its leading life sciences practice, WilmerHale has more than four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

June 7, 2017

Selected 2017 Strategic Alliances, Joint Venture and Licensing Transactions

Our corporate, licensing, intellectual property and regulatory lawyers regularly handle a broad range of strategic alliance, joint venture, licensing,
collaboration, product development, outsourcing, manufacturing, distribution and similar agreements, including many significant deals that are helping to shape the future of science, technology and commerce.

June 7, 2017

Selected 2017 Technology Transactions

For more than four decades, we have represented technology clients in venture capital financings, public offerings, and mergers and acquisitions; handled their licensing, outsourcing, services, joint venture, development and distribution transactions throughout the world; protected their innovations through patent prosecution, portfolio development and litigation; defended their interests in enterprise-critical litigation; and navigated regulatory issues vital to their success.

June 2, 2017

WilmerHale Reps FastMatch in Euronext Acquisition

Euronext announced the acquisition of 90% of FastMatch, Inc. for $153 million initial cash consideration. FastMatch's management will remain invested with a 10% interest, with minority rights.

April 28, 2017

2017 Corporate Reports

WilmerHale's annual IPO, Venture Capital and M&A Reports offer insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.

March 1, 2017

Selected 2017 M&A Transactions

In 2016, we advised clients on more than 75 M&A transactions with an aggregate value of approximately $50 billion, providing guidance in areas including corporate, securities, antitrust and tax. Since 2006, we have participated in more than 1,000 mergers and acquisitions with a total value in excess of $400 billion, ranging from sales of VC-backed companies to multibillion-dollar global mergers.

March 1, 2017

Selected 2017 Public Offerings and Rule 144A Placements

In 2016, we handled more than 35 public offerings and Rule 144A placements raising approximately $25 billion, for leading companies in life sciences, technology, financial services, communications and other industries.

March 1, 2017

Selected 2017 Venture Financings As Company Counsel

In 2016, we served as counsel in approximately 250 venture financings raising nearly $3 billion, including some of the largest and most prominent deals of the year.

November 9, 2016

WilmerHale Reps Hilton Special Committee in $6.5B Investment by HNA Group

The WilmerHale deal team was led by Partner Mark Borden and included Partners Jay Bothwick, Julie Hogan Rodgers, Bill Caporizzo, Erika Robinson, Jonathan Wolfman, Hartmut Schneider, Ben Powell, Jason Chipman; Counsel Eric Hanson; and Associate Cynthia Moon.

Venture Capital

Examples of our experience include:

  • representing biopharmaceutical company Celtaxsys in a $40 million Series D financing. In connection with the financing, Celtaxsys entered into an award and development agreement with Cystic Fibrosis Foundation Therapeutics and licensed its rights in several Eastern European and Asian countries;
  • representing UK company MirriAd in its $15 million Series A round. MirriAd, which makes technology that enables brands to advertise by integrating into popular TV content and music videos, has an office in India and is expanding in the US;
  • representing Viamet Pharmaceuticals Holdings in investments from US, Irish and other UK-based investors; and
  • representing UXPin, a user experience design tool company with teams in Silicon Valley and Poland, in seed and early-stage financings.

Mergers & Acquisitions

Examples of our experience include:

  • representing Regal Entertainment Group in signing of definitive agreement to be acquired by Cineworld Group PLC, the UK's largest cinema operator;
  • representing BAE Systems in its acquisitions of Atlantic Marine, a ship construction and vessel maintenance services provider, and OASYS Technology, an electro-optical systems company, and in the sale of BAE Systems Safety Products and Schroth Safety Products to Takata Corporation;
  • representing Barclays PLC in the sale of its US wealth and investment management business to Stifel Financial, a US-based brokerage and investment banking firm;
  • representing UK game-maker NaturalMotion in its $527 million acquisition of Zynga, the world's leading provider of social game services;
  • representing AVIC International Holding (Zhuhai) Company in its $230 million acquisition of California-based Align Aerospace Holding, as well as in its CFIUS and antitrust filings and in obtaining Chinese regulatory approval for the acquisition;
  • representing Bermuda-based Bacardi Limited in its acquisition of Angel's Share Brands, marking Bacardi's entry into the bourbon category; and
  • representing Lufthansa in numerous M&A transactions, including its acquisition of a 30% stake in bmi British Midland, and joint ventures for its cargo and aircraft maintenance businesses.

IPO/Capital Markets

Examples of our experience include:

  • representing Yandex N.V., the operator of the leading Search engine in Russia, in its initial public offering;
  • representing UK-based biopharmaceutical company Summit Therapeutics in its initial public offering;
  • representing Austrian-based client Nabriva Therapeutics in its initial public offering;
  • representing the underwriters in UK-based biopharmaceutical company Adaptimmune Therapeutics plc's initial public offering; and
  • representing Danaher Corporation in a €2.7 billion offering of senior notes.

Strategic Alliances, Outsourcing & Licensing

Examples of our experience include:

  • counseling on the formation of the Star Alliance—the largest airline alliance in the world, comprising more than 15 international carriers;
  • representing TiVo in a Build-Operate-Transfer M&A and outsourcing deal with Ness USA, in which TiVo contracted  Ness to create a dedicated technology facility in Iasi, Romania, from which Ness will provide application development services to TiVo;
  • representing the National Hockey League in its licensing of the NHL Centre Ice television package in Canada;
  • representing Ophthotech in an ex-US licensing and commercialization agreement with Novartis Pharmaceuticals related to the treatment of wet age-related macular degeneration; and
  • counseling Merrimack Pharmaceuticals in an exclusive license and collaboration agreement with Baxter International for the development and commercialization a development-stage drug for pancreatic cancer outside of the United States and Taiwan.